Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REACH Study: Galleri® in the Medicare Population.

NCT05673018 is registered in ClinicalTrials.gov with GRAIL, Inc. as lead sponsor.

NCT NCT05673018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05673018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REACH Study: Galleri® in the Medicare Population.
Lead sponsor
GRAIL, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
July 12, 2024
Completion date
September 30, 2030
Enrollment
50,000 (estimated)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

cancer